Edition:
United Kingdom

Cellular Biomedicine Group Inc (CBMG.OQ)

CBMG.OQ on NASDAQ Stock Exchange Global Market

19.75USD
17 Sep 2018
Change (% chg)

-- (--)
Prev Close
$19.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
18,128
52-wk High
$23.00
52-wk Low
$9.25

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.54 December 18 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.05 0.05 0.05 --
Quarter Ending Dec-18 1 0.05 0.05 0.05 --
Year Ending Dec-18 2 0.10 0.20 0.00 0.00
Year Ending Dec-19 2 0.41 0.81 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 1 -0.54 -0.54 -0.54 --
Quarter Ending Dec-18 1 -0.57 -0.57 -0.57 --
Year Ending Dec-18 2 -1.72 -1.30 -2.14 -1.84
Year Ending Dec-19 2 -1.97 -1.48 -2.46 -1.72

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.05 0.08 0.03 51.57
Quarter Ending Mar-18 0.05 0.05 0.00 0.97
Quarter Ending Sep-17 0.00 0.11 0.11 0.00
Quarter Ending Jun-17 0.00 0.06 0.06 0.00
Quarter Ending Dec-15 1.50 0.62 0.88 58.67

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.05 0.05 0.05 0.05 --
Quarter Ending Dec-18 0.05 0.05 0.05 0.05 --
Year Ending Dec-18 0.10 0.10 0.10 0.20 0.00
Year Ending Dec-19 0.41 0.41 0.41 0.81 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings